US firm Johnson & Johnson has sought Emergency Use Authorisation (EUA) for its single-dose Covid-19 vaccine in India. J&J had withdrawn its application to the country’s drug regulator as there is no requirement of local bridging trials, after the policy-tweak of fast-tracking foreign-produced Covid-19 vaccines.

Leave a Reply

Your email address will not be published. Required fields are marked *